ABOVE: © ISTOCK.COM, SEZERYADIGAR
The available scientific evidence does not support the use of ivermectin, an antiparastic drug, for the treatment or prevention of COVID-19 outside the context of clinical trials, according to a new report from Cochrane, an international organization that reviews medical research and provides guidance about clinical practice.
Ivermectin has been the subject of much misinformation during the pandemic, prompting multiple health organizations and one of the drug’s manufacturers to issue warnings throughout the past year that there is not sufficient evidence to recommend its use for COVID-19 beyond a trial setting. In the new report, researchers in Germany and the UK sifted through the literature on ivermectin and came to broadly the same conclusion.
“Based on the current very low- to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19,” the authors write in their report, posted ...
